Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maturational delay and asymmetric information flow of brain connectivity in SHR model of ADHD revealed by topological analysis of metabolic networks.

Scientific reports·2020
Same author

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer.

The Korean journal of internal medicine·2020
Same author

Hypofractionated Radiation Therapy for Progressive Heterotopic Ossification: The Relationship between Dose and Efficacy.

International journal of radiation oncology, biology, physics·2020
Same author

Deep learning-based interpretation of basal/acetazolamide brain perfusion SPECT leveraging unstructured reading reports.

European journal of nuclear medicine and molecular imaging·2020
Same author

Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.

European journal of nuclear medicine and molecular imaging·2019
Same author

Clinical implication of 18F-NaF PET/computed tomography indexes of aortic calcification in coronary artery disease patients: correlations with cardiovascular risk factors.

Nuclear medicine communications·2019

Related Experiment Video

Updated: Apr 20, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

8.2K

Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy.

Farzana Alam1, Taslim A Al-Hilal2, Seung Woo Chung2

  • 1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|December 3, 2014
PubMed
Summary

This study introduces a novel nanoparticle system for anti-angiogenesis cancer therapy. The PEG-LHT7/protamine nanocomplex demonstrates improved tumor targeting and inhibits blood vessel growth, offering a promising therapeutic strategy.

Keywords:
Anti-angiogenesisHeparin conjugateProtamineSelf-assembled nanocomplex

More Related Videos

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.8K
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.6K

Related Experiment Videos

Last Updated: Apr 20, 2026

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

8.2K
Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
05:35

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating

Published on: June 23, 2018

7.8K
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.6K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Angiogenesis is crucial for cancer growth and a therapeutic target.
  • Current anti-angiogenic drugs have limitations, including transient efficacy and side effects.
  • Nanoparticle drug delivery systems offer potential to improve anti-angiogenic therapy.

Purpose of the Study:

  • To develop a novel polyelectrolyte complex for enhanced anti-angiogenic therapy.
  • To combine long circulation, passive tumor targeting, and anti-angiogenesis efficacy.
  • To evaluate the performance of a PEG-LHT7/protamine nanocomplex system.

Main Methods:

  • Modification of LHT7 with polyethylene glycol (PEG).
  • Formation of self-assembling PEG-LHT7/protamine nanocomplexes (200nm).
  • Assessment of nanocomplex stability, dissociation in plasma, circulation time, tumor accumulation, and tumor penetration.

Main Results:

  • PEG-LHT7/protamine nanocomplex showed stability in buffer and slow dissociation in plasma.
  • The nanocomplex exhibited a longer mean residence time (15.9h) and increased tumor accumulation compared to free PEG-LHT7.
  • The nanocomplex successfully diffused and extravasated through the tumor's collagen matrix.

Conclusions:

  • Functionalized PEG-LHT7/protamine nanocomplexes are effective for anti-angiogenesis therapy.
  • The developed system demonstrates long circulating, passive targeting, and tumor extravasating abilities.
  • This approach offers a promising strategy to overcome limitations of conventional anti-angiogenic drugs.